Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Jyothi Thundimadathil Ph.D.
Jyothi Thundimadathil, Ph.D., is director of technical operations at CPC Scientific. Prior to that, he was a technical marketing associate at American Peptide Company.
More GEN Content From This Contributor
- Columns: 10 Tips for Designing Peptides
- Columns: Click Chemistry for Peptide Synthesis
- Feature Articles: Review: Glucagon-Like Peptide 1 (GLP-1) in the Treatment of Diabetes